Quantum Pharmaceutical

This page summarises award records that name this supplier and the public buyers listed alongside it. Published names are joined when identifiers or close name matches support the link.

Award history

Published records by year

Each row counts award records linked to this supplier. A single procurement can produce more than one award.

Annual award records and published value assigned to this supplier
Year	Awards	Value counted	Values not counted
2024	1	Value not published	1

Buyer relationships

Buyer relationships by value counted

Ranked by published value assigned to this supplier, then by award count.

SupplierQuantum Pharmaceutical

Source records

Published awards

3 records linked to this supplier.

NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5)
Buyer: NHS England
End date in notice
31 Mar 2028
Value shown in notice
£608,000,000Whole award value; not assigned to one supplier
Official source
Open the official Contracts Finder notice for NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5)
About this figure
- This award names more than one supplier but does not divide the published value between them. The figure is shown for context and is not assigned to one supplier.
View record references
Source
Contracts Finder
Award or lot reference
ocds-b5fd17-5bdeb37b-fea5-437d-9dc4-a1415f3c6f1c / ocds-b5fd17-5bdeb37b-fea5-437d-9dc4-a1415f3c6f1c-1
Aseptically Prepared Dosebanded Medicines 2022
Buyer: HealthTrust Europe LLP (HTE) acting as agent for the University Hospitals of Coventry and Warwickshire NHS Trust (“UHCW”)

Published records by year

Buyer relationships by value counted

Published awards

NHS Framework Agreement for Aseptically Prepared Cytotoxic Medicines and Monoclonal Antibodies for the Treatment of Cancer (Lots 1, 2, 3, 4 and 5)

Aseptically Prepared Dosebanded Medicines 2022

Supply of Nonchemotherapy Compounded Monoclonal Antibodies